Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02120924 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea
A Phase 3 study, sponsored by Actavis.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,009
- Enrollment target
NCT02120924: Completed Phase 3 study, sponsored by Actavis.
NCT02120924 is a Phase 3 study that has completed, run by Actavis. The registered enrollment target is 1,009 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (31% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02120924, a Phase 3 study, has completed, sponsored by Actavis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,009 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the safety and efficacy profiles of a generic Azelaic Acid Gel, 15% to the reference listed Finacea® (azelaic acid) Gel, 15% in the treatment of moderate facial rosacea.
Primary Outcome
Percent change from baseline to Week 12 in the inflammatory (papules and pustules) lesion counts in PP population.
Interventions
- DRUG Vehicle
- DRUG Azelaic acid
- DRUG Finacea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,009 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-09 |
| Phase | Phase 3 |
What the finished NCT02120924 record still lists
NCT02120924 is an interventional study that assigns participants to a tested intervention. Its 1,009 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (31% higher).
The record links to 0 conditions, and to 3 interventions - of which Vehicle is the first listed.
NCT02120924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02120924 about?
NCT02120924 is a clinical study titled "A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea". The purpose of the study is to compare the safety and efficacy profiles of a generic Azelaic Acid Gel, 15% to the reference listed Finacea® (azelaic acid) Gel, 15% in the treatment of moderate facial rosacea.
What is the current status of trial NCT02120924?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,009 participants. The study started on 2013-07. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02120924?
The interventions under investigation include: Vehicle (DRUG), Azelaic acid (DRUG), Finacea (DRUG).
Who is sponsoring clinical trial NCT02120924?
This trial is sponsored by Actavis, which has 79 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02120924's enrollment target sits among peer trials
1,009 295th of 2000 higher than 1,706 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia